Category: Finance
-
NSF-Funded Research Studying Robot-Human Interaction
3 February 2014. Computer scientists at Worcester Polytechnic Institute in Massachusetts are researching interactions between humans and robots in factory and home settings, working either as collaborators with or helpers to people. Research by Worcester Tech faculty Dmitry Berenson and Sonia Chernova, is funded by a pair of three-year grants from National Science Foundation’s National…
-
Pain Therapy Developer Issues IPO, Raises $55 Million
31 January 2014. Cara Therapeutics Inc., a biotechnology company in Shelton, Connecticut, issued its initial public offering (IPO), raising some $55 million. The company issued 5 million shares of common stock, priced in the range of $11 to $13 a share. At noon ET today, the stock is priced at $13.38 a share on the…
-
EU-Funded Project to Develop Biomaterials for Stents
Ceram, a materials technology company in Stoke-on-Trent in the U.K., is coordinating a project funded by the European Commission to develop new biocompatible materials suitable for stents that help keep blood vessels open in the heart. The project, known as Rebiostent, is receiving €4.58 million of its €5.87 million ($US 6.19 million of $7.93 million)…
-
Challenge Seeks Ways to Make Trace Minerals More Available
A new challenge on InnoCentive is looking for different methods for making more available in people’s diets minerals the body needs in small quantities. The competition has a total guaranteed purse of $7,000, with a deadline for submissions of 15 February 2014. InnoCentive in Waltham, Massachusetts conducts open-innovation, crowd-sourcing competitions for corporate and organization sponsors. In…
-
Institutes Developing Power Grid Cybersecurity Technology
Engineering labs at Georgia Institute of Technology in Atlanta are designing a suite of tools to better protect electric power grids, incorporating lessons from recent smart grid developments. The $1.7 million grant from U.S. Department of Energy will fund the work of the Georgia Tech Research Institute, with two other organizations affiliated with Georgia Tech:…
-
DNA Diagnostics Company to Crowdfund Malaria Testing Device
QuantuMDx, a biotechnology company in Newcastle, U.K. says it will start a crowdfunding campaign next month to finance development and field trials of a handheld device to test for malaria. The device is an application of its Q-POC point-of-care diagnostics system, which will be the subject of an Indiegogo campaign beginning 12 February. The company,…
-
Columbia Team to Study Electric Power Switching Transistors
An engineering research group at Columbia University in New York received a $3 million grant from U.S. Department of Energy to create high-power electric switching devices with the speed and efficiency of electronic transistor circuits. The team led by electrical and biomedical engineering professor Ken Shepard — that includes members from MIT, IBM, and the…
-
Becton Dickinson Acquires Point-of-Care Diagnostics Maker
Becton, Dickinson and Company, a medical device manufacturer in Franklin Lakes, New Jersey is buying Alverix Inc., a developer of point-of-care diagnostics equipment in San Jose, California. The purchase price is $40 million, according to a Becton Dickinson statement. Alverix designs testing equipment for physician’s offices, retail and mobile clinics, rural settings, and homes that…
-
Clinical, Drug Discovery Biotech Companies Announce Merger
Senesco Technologies, a clinical stage biotechnology company in Bridgewater, New Jersey says it has a non-binding merger agreement with Fabrus Inc. in La Jolla, California, a drug-discovery biotechnology firm. Financial details of the merger were not disclosed, although the companies plan to reveal the terms when they finalize the agreement in early 2014. Senesco develops…
-
NIH Funding Further Marburg Virus Therapy Development
BioCryst Pharmaceuticals Inc., a developer of drugs for infectious and rare diseases in Durham, North Carolina, says National Institutes of Health (NIH) is continuing its contract with the company to develop a treatment for Marburg virus, the cause of a rare but dangerous tropical disease. The contract extension, says BioCryst, is worth $2.5 million, increasing…